hotspot -WSS

hotspot

author：comprehensive 2025-09-06 08:39:07 - browse：16

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： New rules on organ donation and transplantation 'will bring chaos'

WSS

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Organ transplantation is at a crossroads. Major reform is needed

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

Elizabeth Warren probes abortion access

Q&A: Jennifer Adair on making gene therapy available globally

HIPAA doesn't protect reproductive records from prosecutors

hotspot

hotspot

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Bird flu outbreak in cows is latest avian flu curveball

Medicare details structure of new drug price negotiation program

Cholera vaccine supply gets boost as demand surges globally

Alkermes shareholders re

AbbVie dramatically boosts its spending on lobbying

Continuity nursing helped my family in our darkest PICU moments

What to know about Saharan dust affecting the US and how it can affect health

At least 13 dead in Texas as scorching temps continue

FTC falls short on scrutinizing hospital mergers, study says

leisure time

Bird flu in milk supply is likely coming from asymptomatic cows

7 of the most gruesome medical devices in history

HIPAA doesn't protect reproductive records from prosecutors

Key Senate committee drafts bipartisan bill to stem drug shortages

Review: 'Barbie' will hit you like a shot in the heart

Will.i.am, Britney Spears release new single, 'Mind Your Business'

focus

explore

knowledge

hotspot